CervoMed (CRVO) Invested Capital (2010 - 2018)
CervoMed (CRVO) posted Invested Capital of $550000.0 for Q1 2018, little changed sequentially from $550000.0 in Q4 2017, and down 70.74% YoY from $1.9 million in Q1 2017.
CervoMed (CRVO) Invested Capital (2010 - 2018) Analysis & Trends
CervoMed has reported Invested Capital for 9 years, with the latest figure at $550000.0 in Q1 2018.
- Quarterly Invested Capital fell 70.74% year-over-year to $550000.0 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $550000.0 (down 89.83% YoY) and the FY2017 annual result came in at $550000.0, down 70.74% from the prior year.
- Invested Capital held at $550000.0 in Q1 2018 per CRVO's latest filing, from $550000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $2.4 million in Q2 2017 and troughed at $50000.0 in Q3 2014.
- A 5-year average of $1.0 million and a median of $550000.0 in 2017 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2014 and 2016: Invested Capital slumped 76.34% in 2014, then surged 342.39% in 2016.
- Over 5 years, Invested Capital stood at $50000.0 in 2014, then surged by 749.93% to $424964.0 in 2015, then soared by 342.39% to $1.9 million in 2016, then plunged by 70.74% to $550000.0 in 2017, then changed by 0.0% to $550000.0 in 2018.
- According to Business Quant data, Invested Capital over the past three periods registered $550000.0, $550000.0, and $550000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 550,000.00 |
| Dec 31, 2017 | 550,000.00 |
| Sep 30, 2017 | 550,000.00 |
| Jun 30, 2017 | 2.43 Mn |
| Mar 31, 2017 | 1.88 Mn |
| Dec 31, 2016 | 1.88 Mn |
| Sep 30, 2016 | 1.88 Mn |
| Dec 31, 2015 | 424,964.00 |
| Sep 30, 2014 | 50,000.00 |
| Mar 31, 2014 | 156,358.00 |
| Dec 31, 2013 | 1.67 Mn |
| Sep 30, 2013 | 211,358.00 |
| Jun 30, 2013 | 211,358.00 |
| Mar 31, 2013 | 211,358.00 |
| Dec 31, 2012 | 211,358.00 |
| Sep 30, 2012 | 208,055.00 |
| Jun 30, 2012 | 105,245.00 |
| Dec 31, 2011 | 184,163.00 |
| Sep 30, 2011 | 129,475.00 |
| Jun 30, 2011 | 185,334.00 |